Aviva share price rises 1.4% today: what’s moving AV.L and what to watch next

Aviva share price rises 1.4% today: what’s moving AV.L and what to watch next

London, February 20, 2026, 11:59 GMT — Regular session

  • Aviva shares climbed roughly 1.4% in London morning trading, outpacing the broader FTSE 100.
  • This week, the insurer rolled out a multi-million-pound naming-rights agreement for an arena in Bristol.
  • Next up: Aviva’s full‑year numbers and guidance, due in early March.

Aviva shares added 1.4% to hit 652 pence by mid-morning Friday, briefly reaching as high as 652.8p. The FTSE 100 was ahead roughly 0.6%. Aviva previously settled at 642.8p, still trailing its 12-month peak of 700.6p set in early January.

This shift comes just as Aviva braces for a critical period among UK insurers—earnings, outlooks, and fresh talk on capital returns land soon. Right now, the big focus is payouts: dividends, buybacks, and whatever extra capital the company’s willing to show on its books.

Things look brighter than last week. British inflation cooled to 3.0% in January, according to Reuters—prompting investors to bet the Bank of England could move on rates as early as March. “Investors keep piling into UK assets,” said IG analyst Axel Rudolph. Reuters

Aviva, the UK’s biggest diversified insurer, said Thursday it’s landed a long-term, multi‑million‑pound sponsorship deal giving it naming rights to a new 20,000-seat arena in Bristol, due to open in late 2028. The firm expects the venue will draw about 1.4 million visitors for events each year. Customers will get perks like a 48‑hour ticket pre‑sale window. “Bristol is an important city for Aviva,” CEO Amanda Blanc said. Aviva

The group continues to push on climate and property-risk themes. Aviva, in a report out Wednesday, flagged that 11% of new homes built in England from 2022 to 2024 wound up in medium or high flood-risk zones. The insurer also highlighted that homes constructed after 2009 fall outside Flood Re, the government-backed scheme meant to support affordable flood insurance. “Too many new homes have been built in higher risk areas,” said Jason Storah, CEO for Aviva’s UK & Ireland general insurance business. Aviva

Views on Aviva’s post-Direct Line re-rating are still divided. The Direct Line deal, according to Investors’ Chronicle, closed July 2025. Andreas Van Embden at Peel Hunt thinks Aviva “needs to prove” it can expand both its life assets under administration and push non-life business through the cycle. Over at RBC Capital, Mandeep Jagpal projects annual buybacks in the region of £350 million between 2026 and 2028, pointing out that extra cash “provides management with strategic flexibility.” UBS puts Aviva’s combined yield — dividends and buybacks — at 9.5% by 2028, Investors’ Chronicle reported. investorschronicle.co.uk

Sentiment here still leans hard on rates. Gilt swings hit both insurers’ investment returns and the value of their bond holdings, sometimes shifting their whole capital setup.

Still, things can unravel quickly before results—say, if motor or home pricing softens, or if weather-related losses spike. That would pressure underwriting margins right when investors are counting on the “steady cash return” narrative.

Aviva has set March 5 for its 2025 full-year results, with numbers hitting at 0700 GMT and an investor and analyst call slated for 0830 GMT. This marks the next clear event for the shares.

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company working with customers worldwide. His experience spans satellite communications, telecommunications and technology ventures. He graduated from the Warsaw School of Economics (SGH) and writes about space technology, artificial intelligence, stocks and the technology companies and industries he follows. Follow Marcin Frąckiewicz on Google News, Facebook or LinkedIn.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Kodiak Gas Services

NYSE:KGS • Energy infrastructure 88/100 • ★★★★☆
#2 STRONG BUY

Neurocrine Biosciences

NASDAQ:NBIX • Healthcare 87/100 • ★★★★☆
#3 STRONG BUY

Alphabet Class A

NASDAQ:GOOGL • Communication services 85/100 • ★★★★☆
#4 BUY ON WEAKNESS

Applied Materials

NASDAQ:AMAT • Semiconductor equipment 84/100 • ★★★★☆
#5 ACCUMULATE

JPMorgan Chase

NYSE:JPM • Financials 80/100 • ★★★★☆
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Consumer Confidence • 10:00 ET

A large surprise can reset expectations for household spending and near-term growth, with read-through to Treasuries, USD and cyclical stocks.

#2

New Home Sales • 10:00 ET

Housing remains highly rate-sensitive; the print can move homebuilders, mortgage-sensitive names and the long end of the Treasury curve.

#3

Intuit earnings • After close

Guidance can influence software multiples and sentiment around U.S. small-business activity.

View full calendar
Times and estimates may change. Verify before trading.
FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut
Previous Story

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms
Next Story

Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms